| A stromal lysolipid–autotaxin signaling axis promotes pancreatic tumor progression FR Auciello, V Bulusu, C Oon, J Tait-Mulder, M Berry, S Bhattacharyya, ... Cancer discovery 9 (5), 617-627, 2019 | 234 | 2019 |
| Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer M Janghorban, AS Farrell, BL Allen-Petersen, C Pelz, CJ Daniel, J Oddo, ... Proceedings of the National Academy of Sciences 111 (25), 9157-9162, 2014 | 205 | 2014 |
| Modeling tumor phenotypes in vitro with three-dimensional bioprinting EM Langer, BL Allen-Petersen, SM King, ND Kendsersky, MA Turnidge, ... Cell reports 26 (3), 608-623. e6, 2019 | 203 | 2019 |
| Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer AS Farrell, B Allen-Petersen, CJ Daniel, X Wang, Z Wang, S Rodriguez, ... Molecular Cancer Research 12 (6), 924-939, 2014 | 151 | 2014 |
| Mission possible: advances in MYC therapeutic targeting in cancer BL Allen-Petersen, RC Sears BioDrugs 33 (5), 539-553, 2019 | 149 | 2019 |
| MYC regulates ductal-neuroendocrine lineage plasticity in pancreatic ductal adenocarcinoma associated with poor outcome and chemoresistance AS Farrell, MM Joly, BL Allen-Petersen, PJ Worth, C Lanciault, D Sauer, ... Nature communications 8 (1), 1728, 2017 | 93 | 2017 |
| Activation of PP2A and inhibition of mTOR synergistically reduce MYC signaling and decrease tumor growth in pancreatic ductal adenocarcinoma BL Allen-Petersen, T Risom, Z Feng, Z Wang, ZP Jenny, MC Thoma, ... Cancer research 79 (1), 209-219, 2019 | 72 | 2019 |
| Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer BL Allen-Petersen, CJ Carter, AM Ohm, ME Reyland Oncogene 33 (10), 1306-1315, 2014 | 67 | 2014 |
| Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers CC Farrington, E Yuan, S Mazhar, S Izadmehr, L Hurst, BL Allen-Petersen, ... Journal of Biological Chemistry 295 (3), 757-770, 2020 | 49 | 2020 |
| Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model SM King, DLG Nguyen, VA Gorgen, BR Shepherd, SC Presnell US Patent 9,983,195, 2018 | 27 | 2018 |
| Loss of protein kinase C delta alters mammary gland development and apoptosis BL Allen-Petersen, MR Miller, MC Neville, SM Anderson, KI Nakayama, ... Cell Death & Disease 1 (1), e17-e17, 2010 | 25 | 2010 |
| Three-dimensional bioprinted pancreatic tumor model R Sears, B Allen-Petersen, E Langer US Patent App. 14/820,307, 2016 | 22 | 2016 |
| PP2A and cancer epigenetics: a therapeutic opportunity waiting to happen SL Tinsley, BL Allen-Petersen NAR cancer 4 (1), zcac002, 2022 | 11 | 2022 |
| Microfluidics formulated liposomes of hypoxia activated prodrug for treatment of pancreatic cancer VM Shah, C Dorrell, A Al-Fatease, BL Allen-Petersen, Y Woo, Y Bortnyak, ... Pharmaceutics 14 (4), 713, 2022 | 7 | 2022 |
| Sustained degradation of hyaluronic acid using an in situ forming implant K Hopkins, K Buno, N Romick, AC Freitas dos Santos, S Tinsley, ... PNAS nexus 1 (4), pgac193, 2022 | 3 | 2022 |
| Abstract LT012: The prolyl isomerase PIN1 plays a critical role in fibroblast plasticity to impact pancreatic cancer EM Langer, IA English, KM Kresse, K MacPherson, BL Allen-Petersen, ... Cancer Research 81 (5_Supplement), LT012-LT012, 2021 | 1 | 2021 |
| Three Dimensional Bioprinted Tumor Models for Drug Testing SC Presnell, SM King, DLG Nguyen, JO Minji, RS Pelz, B Allen-Petersen, ... US Patent App. 16/325,523, 2019 | 1 | 2019 |
| The use of protein phosphatase 2A activators in combination therapies for pancreas cancer BL Allen-Petersen, RC Sears Oncotarget 10 (21), 2008, 2019 | 1 | 2019 |
| PP2A-B56α in nutrient scavenging: Tipping the balance from macropinocytosis to cell death in pancreatic cancer G Baral, CM Pfeffer, I Doraivel, SN Filippelli, BL Allen-Petersen Cancer Research 84 (6_Supplement), 4374-4374, 2024 | | 2024 |
| Exploring the mechanism of PP2A regulated cell death via macropinocytosis in pancreatic cancer I Doraivel, G Baral, CM Pfeffer, BL Allen-Petersen Cancer Research 84 (6_Supplement), 1671-1671, 2024 | | 2024 |
